This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Krempler, F. Articles by Patsch, W. Search for Related Content PubMed PubMed Citation Articles by Krempler, F. Articles by Patsch, W.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1998;18:1686-1690.)
© 1998 American Heart Association, Inc.

Original Contributions

Plasma Leptin Levels

Interaction of Obesity With a Common Variant of Insulin Receptor Substrate-1

Presented in part at the 70th Scientific Sessions of the American Heart Association, Orlando, Fla, November 9–12, 1997, and published in abstract form (Circulation. 1997;96[suppl]:I-34).

Franz Krempler; Emanuel Hell; Carmen Winkler; David Breban; ; Wolfgang Patsch

From the Departments of Internal Medicine (F.K.) and Surgery (E.H.), Krankenhaus Hallein, and the Department of Laboratory Medicine (C.W., D.B., W.P.), Landeskrankenanstalten, Salzburg, Austria.

Correspondence to Franz Krempler, MD, Department of Internal Medicine, Krankenhaus Hallein, Bürgermeisterstrasse 34, A-5400 Hallein, Austria. E-mail w.patsch{at}lkasbg.gv.at

Abstract—Obesity is associated with insulin resistance and other major cardiovascular risk factors. A common amino acid polymorphism at codon 972 of the insulin receptor substrate-1 (IRS-1) has been shown to interact with obesity in the expression of insulin resistance. The plasma concentration of the adipocyte-specific hormone leptin is increased in obesity and is correlated with adipose tissue mass. Because in vitro studies demonstrated inhibitory effects of leptin on insulin signaling, leptin may be involved in obesity-associated insulin resistance. To gain insight into the relationship between insulin and leptin in obesity, we studied plasma leptin levels and several cardiovascular risk factors, as well as their modification by the IRS-1 codon 972 genotype, in 156 obese individuals and 131 lean control subjects. In both groups, 10% of the subjects were heterozygous for the IRS-1 codon 972 variant. Obese individuals harboring the IRS-1 variant displayed significantly lower plasma concentrations of leptin than obese subjects without the polymorphism (means, 26.7 versus 37.8 ng/mL, P<0.0293). In a subgroup of obese patients, leptin mRNA abundance was measured in the adipose tissue and was significantly lower in carriers of the IRS-1 variant than in subjects with the wild-type variant (P<0.0291). Our data suggest that insulin signaling influences plasma leptin concentrations at the mRNA expression level and argue against leptin as a major causative factor of insulin resistance.

Key Words: obesity • leptin • insulin resistance • insulin receptor substrate-1

This article has been cited by other articles:

				T. Rice, Y. C. Chagnon, L. Perusse, I. B. Borecki, O. Ukkola, T. Rankinen, J. Gagnon, A. S. Leon, J. S. Skinner, J. H. Wilmore, et al. A Genomewide Linkage Scan for Abdominal Subcutaneous and Visceral Fat in Black and White Families: The HERITAGE Family Study Diabetes, March 1, 2002; 51(3): 848 - 855. [Abstract] [Full Text] [PDF]

				F. Krempler, D. Breban, H. Oberkofler, H. Esterbauer, E. Hell, B. Paulweber, and W. Patsch Leptin, Peroxisome Proliferator-Activated Receptor-{gamma}, and CCAAT/Enhancer Binding Protein-{alpha} mRNA Expression in Adipose Tissue of Humans and Their Relation to Cardiovascular Risk Factors Arterioscler Thromb Vasc Biol, February 1, 2000; 20(2): 443 - 449. [Abstract] [Full Text] [PDF]